Advertisement
Advertisement

SLRN

SLRN logo

Acelyrin Inc

3.29
USD
-0.21
-6.00%
Dec 18, 14:08 UTC -5
Open

Acelyrin Inc Profile

About

Acelyrin Inc. is a clinical biopharma company. It focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep. Acelyrin Inc. is based in Agoura Hills, California.

Info & Links

CEO

Shao-Lee Lin

Headquarters

4149 Liberty Canyon Road
Agoura Hills, CA 91301, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

29

Employees

130

Acelyrin Inc Statistics

Valuation Measures

Market Capitalization2

330.09M

Enterprise Value

113.76M

Enterprise Value/EBITDA(ttm)

-0.32

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.61

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-44.12%

Return on Invested Capital(ttm)

-44.20%

Return on Assets(ttm)

-39.02%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-355.37M

Net Income Available to Common(ttm)

-264.40M

Diluted EPS(ttm)

-2.46

Share Statistics

Beta (5Y Monthly)

1.61

52-Week Change

-52.39%

S&P 500 52-Week Change

27.89%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

100.33M

Dividend Yield

0.00%

Float4

86.68M

% Held by Insiders

13.60%

% Held by Institutions

87.31%

Balance Sheet

Total Cash(mrq)

562.37M

Total Cash Per Share(mrq)

5.61

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.15%

Quick Ratio(mrq)

7.15%

Book Value Per Share(mrq)

5.29

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.83

Free Cash Flow(ytd)

-176.50M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement